Opportunity ID: 322934

General Information

Document Type: Grants Notice
Funding Opportunity Number: PAR-20-071
Funding Opportunity Title: Advanced-Stage Development and Utilization of Research Infrastructure for Interdisciplinary Aging Studies (R33 Clinical Trial Optional)
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Grant
Category of Funding Activity: Health
Category Explanation:
Expected Number of Awards:
Assistance Listings: 93.866 — Aging Research
Cost Sharing or Matching Requirement: No
Version: Synopsis 1
Posted Date: Dec 09, 2019
Last Updated Date: Dec 09, 2019
Original Closing Date for Applications: Nov 16, 2022
Current Closing Date for Applications: Nov 16, 2022
Archive Date: Dec 22, 2022
Estimated Total Program Funding:
Award Ceiling:
Award Floor:

Eligibility

Eligible Applicants: Small businesses
City or township governments
State governments
Native American tribal organizations (other than Federally recognized tribal governments)
Private institutions of higher education
Public and State controlled institutions of higher education
County governments
Native American tribal governments (Federally recognized)
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
For profit organizations other than small businesses
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Special district governments
Public housing authorities/Indian housing authorities
Independent school districts
Others (see text field entitled “Additional Information on Eligibility” for clarification)
Additional Information on Eligibility: Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed.

Additional Information

Agency Name: National Institutes of Health
Description: This FOA invites applications that propose to support advanced-stage development and utilization of novel research infrastructure to advance the science of aging in specific areas requiring interdisciplinary partnerships or collaborations. This FOA will use the NIH Exploratory/Developmental Grants Phase II mechanism to provide support for expanded activities. Applicants are expected to have an existing research infrastructure developed, either through PA-12-064, or with other NIH or non-NIH support. Through this award, investigators will develop a mature and sustainable research infrastructure to support projects that address key interdisciplinary aging research questions.
Link to Additional Information: http://grants.nih.gov/grants/guide/pa-files/PAR-20-071.html
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV
Email:FBOWebmaster@OD.NIH.GOV

Version History

Version Modification Description Updated Date

Folder 322934 Full Announcement-PAR-20-071 -> PAR-20-071-Full-Announcement.pdf

Packages

Agency Contact Information: NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV
Email: FBOWebmaster@OD.NIH.GOV
Who Can Apply: Organization Applicants

Assistance Listing Number Competition ID Competition Title Opportunity Package ID Opening Date Closing Date Actions
FORMS-E Use for due dates on or before May 24, 2020 PKG00257039 Jan 16, 2020 May 24, 2020 View
FORMS-F Use for due dates on or before January 24, 2022 PKG00260081 Jan 16, 2020 Jan 24, 2022 View
FORMS-G Use for due dates on or after January 25, 2022 PKG00271859 Feb 01, 2022 Nov 16, 2022 View
FORMS-H Use for due dates on or after January 25, 2023 PKG00278260 Nov 10, 2022 Nov 16, 2022 View

Package 1

Mandatory forms

322934 RR_SF424_2_0-2.0.pdf

322934 PHS398_CoverPageSupplement_4_0-4.0.pdf

322934 RR_OtherProjectInfo_1_4-1.4.pdf

322934 PerformanceSite_2_0-2.0.pdf

322934 RR_KeyPersonExpanded_2_0-2.0.pdf

322934 RR_Budget_1_4-1.4.pdf

322934 PHS398_ResearchPlan_4_0-4.0.pdf

Optional forms

322934 RR_SubawardBudget30_1_4-1.4.pdf

322934 PHS_AssignmentRequestForm_2_0-2.0.pdf

Package 2

Mandatory forms

322934 RR_SF424_2_0-2.0.pdf

322934 PHS398_CoverPageSupplement_5_0-5.0.pdf

322934 RR_OtherProjectInfo_1_4-1.4.pdf

322934 PerformanceSite_2_0-2.0.pdf

322934 RR_KeyPersonExpanded_2_0-2.0.pdf

322934 RR_Budget_1_4-1.4.pdf

322934 PHS398_ResearchPlan_4_0-4.0.pdf

322934 PHSHumanSubjectsAndClinicalTrialsInfo_2_0-2.0.pdf

Optional forms

322934 RR_SubawardBudget30_1_4-1.4.pdf

322934 PHS_AssignmentRequestForm_3_0-3.0.pdf

Package 3

Mandatory forms

322934 RR_SF424_5_0-5.0.pdf

322934 PHS398_CoverPageSupplement_5_0-5.0.pdf

322934 RR_OtherProjectInfo_1_4-1.4.pdf

322934 PerformanceSite_4_0-4.0.pdf

322934 RR_KeyPersonExpanded_4_0-4.0.pdf

322934 RR_Budget_3_0-3.0.pdf

322934 PHS398_ResearchPlan_4_0-4.0.pdf

322934 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf

Optional forms

322934 RR_SubawardBudget30_3_0-3.0.pdf

322934 PHS_AssignmentRequestForm_3_0-3.0.pdf

Package 4

Mandatory forms

322934 RR_SF424_5_0-5.0.pdf

322934 PHS398_CoverPageSupplement_5_0-5.0.pdf

322934 RR_OtherProjectInfo_1_4-1.4.pdf

322934 PerformanceSite_4_0-4.0.pdf

322934 RR_KeyPersonExpanded_4_0-4.0.pdf

322934 RR_Budget_3_0-3.0.pdf

322934 PHS398_ResearchPlan_5_0-5.0.pdf

322934 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf

Optional forms

322934 RR_SubawardBudget30_3_0-3.0.pdf

322934 PHS_AssignmentRequestForm_3_0-3.0.pdf

2025-07-09T11:25:16-05:00

Share This Post, Choose Your Platform!

About the Author: